| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 133.352 | 117.647 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 133.352 | 117.648 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 788 | 40.794 | 50.457 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -788 | 92.558 | 67.191 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -788 | 91.251 | 64.085 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Gynlid Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 19.519 | 27.406 |
| Current Assets | - | - | - | - | - | - | - | 33 | 88.180 | 64.873 |
| Inventories | - | - | - | - | - | - | - | 0 | 213 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 83.580 | 62.557 |
| Cash | - | - | - | - | - | - | - | 33 | 4.387 | 2.316 |
| Shareholders Funds | - | - | - | - | - | - | - | -748 | 90.506 | 64.223 |
| Social Capital | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | - | 781 | 17.193 | 28.057 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynlid Med S.r.l.